报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 4.2% | 71.43% | 83.41% | 65/128 | 4.74% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 2.29% | 6.51% | 154.44% | 71/128 | 3.02% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.9% | -51.61% | -66.79% | 77/128 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 2.71% | -78.04% | 10.61% | 83/128 | 4.98% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 2.45% | -76.05% | 13.95% | 92/128 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 2.15% | -76.5% | 15.59% | 77/128 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.86% | -24.39% | -84.93% | 62/128 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 12.34% | -36.42% | 20.63% | 53/128 | 13.37% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 10.23% | -34.51% | 11.8% | 54/128 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 9.15% | -33.7% | 271.95% | 36/128 | 9.31% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 2.46% | 2% | -87.33% | 62/128 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 19.41% | -21.99% | 24.26% | 42/128 | 17.51% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 15.62% | 2% | 13.19% | 37/128 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 13.8% | 10.75% | -44.53% | 26/128 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2020-12-31 | 24.88% | 11.57% | 99.68% | 35/128 | 25.89% | 热景生物 | 57.63% | 行业排名> |
2020-06-30 | 12.46% | 2% | -44.13% | 37/128 | 15.16% | 中红医疗 | 168% | 行业排名> |
2019-12-31 | 22.3% | 9.26% | 9.26% | 33/128 | 14.36% | 圣湘生物 | 112.46% | 行业排名> |
2018-12-31 | 20.41% | 31% | 31% | 30/128 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
2017-12-31 | 15.58% | 2% | 2% | 41/128 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |